Home Citric acid as the last therapeutic approach in an acute life-threatening metabolic decompensation of propionic acidaemia
Article
Licensed
Unlicensed Requires Authentication

Citric acid as the last therapeutic approach in an acute life-threatening metabolic decompensation of propionic acidaemia

  • Manuela Siekmeyer , Stefanie Petzold-Quinque EMAIL logo , Friederike Terpe , Skadi Beblo , Rolf Gebhardt , Franziska Schlensog-Schuster , Wieland Kiess and Werner Siekmeyer
Published/Copyright: February 15, 2013

Abstract

The tricarboxylic acid (TCA) cycle represents the key enzymatic steps in cellular energy metabolism. Once the TCA cycle is impaired in case of inherited metabolic disorders, life-threatening episodes of metabolic decompensation and severe organ failure can arise. We present the case of a 6 ½-year-old girl with propionic acidaemia during an episode of acute life-threatening metabolic decompensation and severe lactic acidosis. Citric acid given as an oral formulation showed the potential to sustain the TCA cycle flux. This therapeutic approach may become a treatment option in a situation of acute metabolic crisis, possibly preventing severe disturbance of energy metabolism.


Corresponding author: Stefanie Petzold-Quinque, MD, Department of Women and Child Health, University Hospital, University of Leipzig, Liebigstr. 20a, 04103 Leipzig, Germany, Phone: +49-341-97 26 424, Fax: +49-341-97 26 449

We thank the nurses and physicians who helped in caring for the girl, and her family for their cooperation and help.

References

1. Childs B, Nyhan WL, Borden M, Bard L, Cooke RE. Idiopathic hyperglycinemia and hyperglycinuria: a new disorder of amino acid metabolism. Pediatrics 1961;27:522–38.Search in Google Scholar

2. Hommes FA, Kuipers JR, Elema JD, Jansen JF, Jonxis JH. Propionic acidemia, a new inborn error of metabolism. Pediatr Res 1968;2:519–24.Search in Google Scholar

3. Hsia YE, Scully KJ, Rosenberg LE. Defective propionate carboxylation in ketotic hyperglycinaemia. Lancet 1969;i: 757–8.Search in Google Scholar

4. Desviat LR, Pérez B, Pérez-Cerdá C, Rodríguez-Pombo P, Clavero S, et al. Propionic acidemia: mutation update and functional and structural effects of the variant alleles. Mol Genet Metab 2004;83:28–37 (Review).Search in Google Scholar

5. Ugarte M, Pérez-Cerdá C, Rodríguez-Pombo P, Desviat LR, Pérez B, et al. Overview of mutations in the PCCA and PCCB genes causing propionic acidemia. Hum Mutat 1999;14: 275–82.Search in Google Scholar

6. Lücke T, Pérez-Cerdá C, Baumgartner M, Fowler B, Sander S, et al. Propionic acidemia: unusual course with late onset and fatal outcome. Metabolism 2004;53:809–10.Search in Google Scholar

7. Sass JO, Hofmann M, Skladal D, Mayatepek E, Schwahn B, et al. Propionic acidemia revisited: a workshop report. Clin Pediatr (Phila) 2004;43:837–43.Search in Google Scholar

8. Mayatepek E, Schulze A. Metabolic decompensation and lactic acidosis in propionic acidaemia complicated by thiamine deficiency. J Inherit Metab Dis 1999;22:189–90.Search in Google Scholar

9. Nguyen NH, Morland C, Gonzalez SV, Rise F, Storm-Mathisen J, et al. Propionate increases neuronal histone acetylation, but is metabolized oxidatively by glia. Relevance for propionic acidemia. J Neurochem 2007;101:806–14.Search in Google Scholar

10. Matsuishi T, Stumpf DA, Chrislip K. The effects of malate on propionate mitochondrial toxicity. Biochem Med Metab Biol 1991;46:177–84.Search in Google Scholar

11. Filipowicz HR, Ernst SL, Ashurst CL, Pasquali M, Longo N. Metabolic changes associated with hyperammonemia in patients with propionic acidemia. Mol Genet Metab 2006;88:123–30.Search in Google Scholar

12. Matsuishi T, Stumpf DA, Seliem M, Eguren LA, Chrislip K. Propionate mitochondrial toxicity in liver and skeletal muscle: acyl CoA levels. Biochem Med Metab Biol 1991;45:244–53.Search in Google Scholar

13. van der Meer SB, Poggi F, Spada M, Bonnefont JP, Ogier H, et al. Clinical outcome and long-term management of 17 patients with propionic acidemia. Eur J Pediatric 1996;155: 205–10.Search in Google Scholar

14. De Keyzer Y, Valayannopoulos V, Benoist JF, Batteux F, Lacaille F, et al. Multiple OXPHOS deficiency in the liver, kidney, heart, and skeletal muscle of patients with methylmalonic aciduria and propionic aciduria. Pediatr Res 2009;66:91–5.Search in Google Scholar

15. Deodato F, Boenzi S, Santorelli FM, Dionisi-Vici C. Methylmalonic and propionic aciduria. Am J Med Genet C Semin Med Genet 2006;142:104–12 (Review).Search in Google Scholar

16. Kraus JP, Spector E, Venezia S, Estes P, Chiang PW, et al. Mutation analysis in 54 propionic acidemia patients. J Inherit Metab Dis 2012;35:51–63.Search in Google Scholar

17. Schwab MA, Sauer SW, Okun JG, Nijtmans LG, Rodenburg RJ, et al. Secondary mitochondrial dysfunction in propionic aciduria: a pathogenic role for endogenous mitochondrial toxins. Biochem J 2006;398:107–12.Search in Google Scholar

18. Scholl-Bürgi S, Sass JO, Zschocke J, Karall D. Amino acid metabolism in patients with propionic acidaemia. J Inherit Metab Dis 2012;35:65–70.Search in Google Scholar

19. Wajner M, Goodman SI. Disruption of mitochondrial homeostasis in organic acidurias: insights from human and animal studies. J Bioenerg Biomembr 2011;43:31–8 (Review).Search in Google Scholar

20. Cheema-Dhadli S, Leznoff CC, Halperin ML. Effect of 2-methylcitrate on citrate metabolism: implications for the management of patients with propionic acidemia and methylmalonic aciduria. Pediatr Res 1975;9:905–8.Search in Google Scholar

21. Knerr I, Weinhold N, Vockley J, Gibson KM. Advances and challenges in the treatment of branched-chain amino/keto acid metabolic defects. J Inherit Metab Dis 2012;35:29–40.Search in Google Scholar

22. Ahmad A, Kahler SG, Kishnani PS, Artigas-Lopez M, Pappu AS, et al. Treatment of pyruvate carboxylase deficiency with high doses of citrate and aspartate. Am J Med Genet 1999;87: 331–8.Search in Google Scholar

23. Mochel F, DeLonlay P, Touati G, Brunengraber H, Kinman RP, et al. Pyruvate carboxylase deficiency: clinical and biochemical response to anaplerotic diet therapy. Mol Genet Metab 2005;84:305–12.Search in Google Scholar

24. Roe CR, Sweetman L, Roe DS, David F, Brunengraber H. Treatment of cardiomyopathy and rhabdomyolysis in long-chain fat oxidation disorders using an anaplerotic odd-chain triglyceride. J Clin Invest 2002;110:259–69.Search in Google Scholar

25. Inoue K, Zhuang L, Maddox DM, Smith SB, Ganapathy V. Structure, function, and expression pattern of a novel sodium-coupled citrate transporter (NaCT) cloned from mammalian brain. J Biol Chem 2002;277:39469–76.Search in Google Scholar

26. Inoue K, Zhuang L, Ganapathy V. Human Na+-coupled citrate transporter: primary structure, genomic organization, and transport function. Biochem Biophys Res Commun 2002;299:465–71.Search in Google Scholar

27. Gopal E, Miyauchi S, Martin PM, Ananth S, Srinivas SR, et al. Expression and functional features of NaCT, a sodium-coupled citrate transporter, in human and rat livers and cell lines. Am J Physiol Gastrointest Liver Physiol 2007;292:G402–8.Search in Google Scholar

28. Mycielska ME, Patel A, Rizaner N, Mazurek MP, Keun H, et al. Citrate transport and metabolism in mammalian cells. BioEssays 2009;31:10–20.Search in Google Scholar

Received: 2012-5-8
Accepted: 2013-1-16
Published Online: 2013-02-15
Published in Print: 2013-05-01

©2013 by Walter de Gruyter Berlin Boston

Articles in the same Issue

  1. Masthead
  2. Masthead
  3. Editorial
  4. Success has many fathers, failure is orphan
  5. Review Article
  6. Normosmic idiopathic hypogonadotropic hypogonadism: update on the genetic background and future challenges
  7. Original Articles
  8. Temporary brittle bone disease: association with intracranial bleeding
  9. Asymmetric dimethylarginine (ADMA) and L-arginine levels in children with glycogen storage disease type I
  10. Application of liquid chromatography-tandem mass spectrometry in the diagnosis and follow-up of maple syrup urine disease in a Chinese population
  11. The role of uncoupling protein 2 and 3 genes polymorphism and energy expenditure in obese Indonesian children
  12. Thyroid dysfunctions of prematurity and their impacts on neurodevelopmental outcome1)
  13. Frequency of the E23K polymorphism of the KCNJ11 gene in children born small for gestational age and its influence on auxological and metabolic parameters in the prepubertal period
  14. Reference intervals for serum thyroid hormones in preterm hospitalized infants1)
  15. The clinical and biochemical presentation of vitamin D deficiency and insufficiency in children and adolescents
  16. A risk score for identifying overweight adolescents with dysglycemia in primary care settings1)
  17. Thyroid function and morphology in overweight and obese children and adolescents in a Chinese population
  18. Propionic acidaemia: demographic characteristics and complicationsa
  19. Negative correlation between serum IL-6 level and cardiorespiratory fitness in 10- to 11-year-old boys with increased BMI
  20. Penile length and genital anomalies in Egyptian male newborns: epidemiology and influence of endocrine disruptors
  21. Efficacy of vitamin D loading doses on serum 25-hydroxy vitamin D levels in school going adolescents: an open label non-randomized prospective trial
  22. Characteristics of infants admitted with hypoglycemia to a neonatal unit
  23. Increasing thyroid-stimulating hormone is associated with impaired glucose metabolism in euthyroid obese children and adolescents
  24. The role of FTO genotype on eating behavior in obese Sardinian children and adolescents
  25. Prevalence of multiple forms of autoimmunity in Egyptian patients with Turner syndrome: relation to karyotype
  26. A novel DAX-1 mutation presented with precocious puberty and hypogonadotropic hypogonadism in different members of a large pedigree
  27. Patient Reports
  28. Pseudohypoparathyroidism type Ia: a novel GNAS mutation in a Brazilian boy presenting with an early primary hypothyroidism
  29. Diabetic ketoacidosis with cerebral hemorrhage and alpha coma in an adolescent female
  30. A novel mutation in thyrotropin (thyroid-stimulating hormone) gene in congenital hypothyroidism
  31. Citric acid as the last therapeutic approach in an acute life-threatening metabolic decompensation of propionic acidaemia
  32. A case of autosomal dominant osteopetrosis type II with a novel TCIRG1 gene mutation
  33. The interpretation of color – an endocrine cause of skin discoloration mimicking cyanosis
  34. Novel heterozygous thyrotropin receptor mutation presenting with neonatal hyperthyrotropinaemia, mild thyroid hypoplasia and absent uptake on radioisotope scan
  35. Turner Syndrome and apparent absent uterus: a case report and review of the literature
  36. 10.1515/jpem-2012-0133
  37. Vaginal bleeding in a 4-month-old preterm girl: extreme minipuberty mimicking central precocious puberty
  38. A rare case of isolated Cushing syndrome in a 3-month-old boy
  39. Letters to the Editors
  40. Gynecomastia in puberty is usually asymptomatic and regresses spontaneously
  41. Is endometriosis ultimately the end result of the interplay between interferon-γ (IFN-γ) and the HOXA10 gene network?
  42. Does treatment with L-selenomethionine reduce thyroid volume in euthyroid children with autoimmune thyroiditis?
  43. Meetings
  44. Meetings Calendar
Downloaded on 28.10.2025 from https://www.degruyterbrill.com/document/doi/10.1515/jpem-2012-0148/pdf
Scroll to top button